Discovering the cause of inflammatory bowel disease: Lessons from animal models

Current Opinion in Gastroenterology

Volumn 16, Issue 4, 2000, Pages 310-317

  Arseneau, Kristen O ^a   Pizarro, Theresa T ^a   Cominelli, Fabio ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; DEXTRAN; INTERLEUKIN 10; INTERLEUKIN 2; SODIUM SULFATE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; BACTERIAL FLORA; COLITIS; CROHN DISEASE; DISEASE MODEL; ENTERITIS; GENE TARGETING; GENETIC RECOMBINATION; NONHUMAN; PATHOGENESIS; T LYMPHOCYTE; TRANSGENIC MOUSE; ULCERATIVE COLITIS;

EID: 0034463241     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200007000-00004     Document Type: Article

References (64)

1. Inflammatory bowel disease
2. Lessons from genetically engineered animal models. XI: Novel mouse models to study pathogenic mechanisms of Crohn's disease
3. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease
4. Antibodies to interleukin 12 abrogate established experimental colitis in mice
5. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
6. Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-G2b fusion protein in mice
7. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses
8. A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune colitis
9. The effect of antioxidant therapy on colonic inflammation in the rat
10. The effect of an inhibitor of matrix metalloproteinases an colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease
11. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis
12. Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease
13. Effect of dehydroleucodine in experimental colitis in rats and mice
14. The effect of Oren-gedoku-to on experimental colitis in rats
15. Beneficial effects of ropivacaine in rat experimental colitis
16. Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats
17. Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: Therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats
18. Intestinal inflammation in adhesion molecule-deficient mice: An assessment of P-selectin alone and in combination with ICAM-1 or E-selectin
19. Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis
20. Hyperthermia prevents functional, histological and biochemical abnormalities induced during ileitis
21. Mouse colitis induced by Escherichia coli producing Yersinia enterocolitica 60-kilodalton heat-shock protein: Light and electron microscope study
22. Does microcirculation play a role in the pathogenesis of inflammatory bowel diseases? Answers from intravital microscopic studies in animal models
23. Temporal patterns of colonic blood flow and tissue damage in an animal model of colitis
24. Cigarette smoke aggravates experimental colitis in rats
25. Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats
26. Dextran sulfate sodium (DSS) colitis in rats: Clinical, structural, and ultrastructural aspects
27. Depletion of colonic detoxication enzyme activity in mice with dextran sulphate sodium-induced colitis
28. Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis
29. Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice
30. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 [ELAM-1] or intercellular adhesion molecule-1 [ICAM-1])
31. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis
32. Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis
33. Human [Gly2] GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis
34. Expression of NOS II and its role in experimental small bowel ulceration in rats
35. Effect of MEN 11467, a new tachykinin NK1 receptor antagonist, in acute rectocolitis induced by acetic acid in guinea-pigs
36. Effects of histamine H-1 antagonist dithiaden on acetic acid-induced colitis in rats
37. Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease
38. + TCRbetabeta+ T cells in TCR alpha-chain- deficient mice by gut-derived antigens
39. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice
40. + transgenic T cells in spontaneous inflammatory bowel disease in lymphopenic mice
41. Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis
42. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: Amelioration of ongoing inflammatory bowel disease with an OX40-G fusion protein, but not with an OX40 ligand-G fusion protein
43. -/- mice
44. Increased nuclear factor-kappaB activation in colitis of interleukin-2-deficient mice
45. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor
46. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
47. A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice
48. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice
49. Expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in acute and chronic inflammation
50. Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: Effects of flora and proinflammatory cytokines
51. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease: Crohn's Disease cA2 Study Group
52. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
53. + T cells are important for the balance between protective and pathogenic cell-mediated immunity
54. Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice on transfer of CD4(+)CD45RB(hi) T cells
55. Tumour necrosis factoralpha (TNF-alpha) transcription and translation in the CD4(+) T cell-transplanted scid mouse model of colitis
56. An essential role for interleukin-10 in the function of regulatory T cells which inhibit intestinal inflammation
57. Severe colitis in mice with aberrant thymic selection
58. Characterization of spontaneous colitis in cotton-top tamarins (Saguinus oedipus) and its response to sulfasalazine
59. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice
60. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain
61. Colonization of microflora in mice: Mucosal defense against luminal bacteria
62. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in routine inflammatory bowel disease
63. Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle
64. Protection from radiation-induced colitis requires MHC class II antigen expression by cells of hemopoietic origin